此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

COVID-19 and Vitamin D: Length of Hospital Stay and Mortality

2022年2月3日 更新者:Sevan ÇETİN ÖZBEK、Yuksek Ihtisas University

Vitamin D Level: Reflections of a Public Health Issue in the COVID-19 Pandemic. Does it Affect Mortality and Length of Hospital Stay?

The lack of a pharmacological treatment in the COVID-19 pandemic has pushed scientists to search for this issue. Maintaining optimal health is parallel to adequate and balanced nutrition. In this context, can the protective properties of vitamin D play an important role in this pandemic? brought with it the thought. In this study, it was aimed to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease.

研究概览

详细说明

This research was conducted to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease. For this, the approval of the Ministry of Health and then the ethics committee was obtained. For this reason, patients with positive PCR tests and hospitalized patients with vitamin D levels in their biochemistry were included in the study.

The data of the patients were obtained from the medical records. Information such as age, gender, comorbidities, length of hospital stay, vitamin D level were included in the study. According to the statistical analyzes obtained from these data, it has been shown that vitamin D level has no effect on mortality and hospital stay in COVID-19 disease.

研究类型

观察性的

注册 (实际的)

168

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Ankara、火鸡、06800
        • Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

取样方法

概率样本

研究人群

Adult patients with positive COVID-19 PCR (Polymerase Chain Reaction) test and vitamin D level in biochemical parameters, who applied to Ankara City Hospital Neurology-Orthopedics Hospital between 01 August and 31 October 2020.

描述

Inclusion Criteria:

  • COVID-19 PCR (Polymerase Chain Reaction) test positive
  • Vitamin D level in biochemical parameters
  • Adult patients hospitalized for COVID-19

Exclusion Criteria:

-Patients using drugs that may affect vitamin D absorption, such as corticosteroids, cholesterol-lowering agents, phenobarbital and phenytoin-containing agents

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Patients with COVID-19 + with vitamin D levels
Patients with COVID-19 + and vitamin D levels were included in the study retrospectively. Vitamin D level was categorized into 3 groups as inadequacy, deficiency and normal from medical records. No intervention was made.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Level of Vitamin D
大体时间:1 month later
Vitamin D levels of patients with a diagnosis of COVID-10. These results were categorized at the level of deficiency/insufficiency/normal.
1 month later
Relationship between vitamin D level and mortality
大体时间:1 month later
Relationship between survival and death by categorized vitamin D level.
1 month later
Relationship between vitamin D level and hospital stay
大体时间:1 month later
Length of hospital stay by categorized vitamin D level.
1 month later

次要结果测量

结果测量
措施说明
大体时间
Effects of additional diseases (Diabetes mellitus, hypertension, etc.) on hospital stay and mortality
大体时间:1 month later.
Evaluation of the impact of comorbidities on survival during COVID-19 disease.
1 month later.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Levent Öztürk, MD、Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年8月21日

初级完成 (实际的)

2021年11月9日

研究完成 (实际的)

2021年11月16日

研究注册日期

首次提交

2022年2月2日

首先提交符合 QC 标准的

2022年2月2日

首次发布 (实际的)

2022年2月3日

研究记录更新

最后更新发布 (实际的)

2022年2月21日

上次提交的符合 QC 标准的更新

2022年2月3日

最后验证

2022年2月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

维生素 D 缺乏症的临床试验

3
订阅